MAC
41
-5
DHI
65
-3
ROST
66
-2
DUK
54
-5
MSI
58
-5
STT
56
2
COST
53
-3
CTAS
50
-6
FAST
44
-4
SWKS
56
3
AAPL
53
-2
USB
65
12
SRE
66
-2
ITW
42
-4
CMS
55
-3
EQT
53
2
TDC
42
-2
LOW
56
-2
CCL
65
-3
TGNA
69
2
MAC
41
-5
DHI
65
-3
ROST
66
-2
DUK
54
-5
MSI
58
-5
STT
56
2
COST
53
-3
CTAS
50
-6
FAST
44
-4
SWKS
56
3
AAPL
53
-2
USB
65
12
SRE
66
-2
ITW
42
-4
CMS
55
-3
EQT
53
2
TDC
42
-2
LOW
56
-2
CCL
65
-3
TGNA
69
2
Financhill
Back

Adaptimmune Therapeutics Plc - ADR Vs. Biodexa Pharmaceuticals Plc - ADR Industry Stock Comparison

Sell
19

ADAP
Adaptimmune Therapeutics Plc - ADR

Last Price:
$0.06
Seasonality Move:
-14.8%
Sell
26

BDRX
Biodexa Pharmaceuticals Plc - ADR

Last Price:
$7.05
Seasonality Move:
-20.97%
Sell
19
Adaptimmune Therapeutics Plc - ADR (ADAP) is a Sell

Is Adaptimmune Therapeutics Plc - ADR a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics Plc - ADR [ADAP] share price is $0.07. The Score for ADAP is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
26
Biodexa Pharmaceuticals Plc - ADR (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc - ADR a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals Plc - ADR [BDRX] share price is $7.04. The Score for BDRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics Plc - ADR's stock price today?

  • The Adaptimmune Therapeutics Plc - ADR share price today is $0.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals Plc - ADR's stock price today?

  • The Biodexa Pharmaceuticals Plc - ADR share price today is $7.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing slight buying pressure.

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 29.3 Sell
Chaikin Money Flow: 1485905 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.07 - 0.27) Sell
Bollinger Bands (100): (0.17 - 0.31) Sell

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 36.94 Sell
Chaikin Money Flow: 1530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.06 - 8.92) Sell
Bollinger Bands (100): (8.42 - 14.34) Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.08 Sell
20-day SMA: 0.15 Sell
50-day SMA: 0.22 Sell
200-day SMA: 0.43 Sell
8-day EMA: 0.09 Sell
20-day EMA: 0.13 Sell
50-day EMA: 0.2 Sell
200-day EMA: 0.43 Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.94 Buy
20-day SMA: 7.78 Sell
50-day SMA: 8.86 Sell
200-day SMA: 27.02 Sell
8-day EMA: 7.08 Sell
20-day EMA: 7.62 Sell
50-day EMA: 9.29 Sell
200-day EMA: 450.94 Sell

Adaptimmune Therapeutics Plc - ADR Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.03 per share.

Biodexa Pharmaceuticals Plc - ADR Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.40 per share.

Adaptimmune Therapeutics Plc - ADR Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biodexa Pharmaceuticals Plc - ADR Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):